Norwood Procedure Cost in Ghaziabad

The Norwood procedure is the first of three surgeries done to correct hypoplastic left heart syndrome (HLHS). This congenital heart defect occurs in only a few babies and involves underdevelopment of the left side of the heart. It assists in redirecting blood flow so the single working right ventricle can pump blood to the lungs and the body.

This disorder is usually diagnosed before birth with a fetal echocardiogram or after birth for evidence such as blue skin colouration (cyanosis), weak feeding, quick breathing, or sleepiness. Early neonatal intervention and surgery consultation are mandatory.

Preparation is initiated in the neonatal intensive care unit (NICU) where the infant is stabilised with medications (e.g., prostaglandin to maintain patency of the ductus arteriosus). Diagnostic studies such as echocardiograms, chest X-rays, and blood work are obtained to prepare for surgery.

During the Norwood procedure, the surgeon creates a new aorta from the current pulmonary artery and attaches it to the right ventricle. A shunt (Blalock-Taussig or Sano shunt) is inserted to deliver blood to the lungs, enabling the right ventricle to assume systemic and pulmonary circulation.

The operation is involved and lasts 5 to 6 hours or more. It is done under general anesthesia with a heart-lung bypass machine. A few weeks' hospital stay in the NICU or cardiac ICU is anticipated after surgery.

• Bleeding
• Infection
• Arrhythmias
• Low cardiac output
• Neurological injury
• Shunt blockage

The main advantage is lifesaving palliation for babies with HLHS. It helps the infant to live and develop until it can receive the subsequent phases of treatment: the Glenn and Fontan surgeries.

Recovery consists of intensive observation in the ICU, mechanical ventilation, and weaning progressively off support. Feeding support and medications to sustain cardiac function are typically needed. Ongoing growth and observation are necessary until the following procedure at 4\u20136 months old.

Survival has dramatically improved; early survival is approximately 75\u201385% at advanced centres. Long-term prognosis is based on global heart function, presence of additional anomalies, and success of the staged surgical approach.